journal article·2022-10-26Open access

Development of an Artificial 3D Liver Phantom for Analysis of Radiotherapeutic Effects In Vitro

Christina Stengl, Shahrouz Ghafoory, Artur Weidner, Brennah Murphy, Stefan Wölfl

Applied Sciences· Volume 12· Issue 21

Abstract

Over recent decades, stereotactic body radiotherapy has garnered increasing popularity. Unfortunately, conventional preclinical 2D in vitro models are often insufficient for studying radiotherapy effects. Therefore, in this study, we developed a novel anthropomorphic in vitro liver phantom, which simulates the relevant hepatocellular carcinoma (HCC) tumor microenvironment and spatial organization. The liver phantom was 3D printed, filled with tissue-mimicking agarose mixture, and designed to fit ten microfluidic chips (MCs), in which HepG2 cells were seeded. Airtight MCs induced hypoxic conditions, as verified by Hif1α staining. Irradiation was conducted with 20 Gy in one fraction using a CyberKnife, in either a 2D setup, or by irradiating MCs arranged in the 3D-printed liver model using an individually calculated treatment plan. Post-irradiation cellular damage was determined via γH2AX staining. Here, we demonstrate a new physiologically relevant approach to model HCC pathology following radiotherapy. Comparing γH2AX staining in normoxic conditions to cells grown in MCs (hypoxic conditions) revealed a reduction in cellular damage of 30.24% (p = 0.0001) in the hypoxic environment. Moreover, we compared the scattering effect of radiation on a conventional 2D in vitro model to our new 3D anthropomorphic liver phantom and observed a significant γH2AX intensity reduction of 9.6% (p = 0.0294) in HepG2 cells irradiated in the phantom. Our approach of utilizing a liver phantom takes into account the hypoxic tumor microenvironment and 3D scattering effects of tissue irradiation, thereby modeling both physical and biological parameters of HCC tumors. The use of tissue phantoms lays the groundwork for future examination of other hypoxic tumors and offers a more comprehensive approach for screening and analysis of novel cancer therapeutics.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Advanced Radiotherapy Techniques · Radiation Therapy and Dosimetry · Ultrasound and Hyperthermia Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Medical Physics in Radiation Oncology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany

Institute for Pharmacy and Molecular Biotechnology, Im Neuenheimer Feld 364, 69120 Heidelberg, Germany

Faculty of Medicine, University of Heidelberg, Im Neuenheimer Feld 672, 69120 Heidelberg, Germany

The Wistar Institute, 3601 Spruce Street Philadelphia, Philadelphia, PA 19104, USA

Funding

German Ministry for Education and Research

References (21)

Show source-provided references
1. Hypoxia-inducible factors in hepatocellular carcinoma (Review)
2. Hypoxic microenvironment and hepatocellular carcinoma treatment10.20517/2394-5079.2018.27 ↗
3. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma10.1016/j.jhep.2018.03.019 ↗
4. NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.201710.6004/jnccn.2017.0059 ↗
5. Indications of external radiotherapy for hepatocellular carcinoma from updated clinical guidelines: Diverse global viewpoints10.3748/wjg.v26.i4.393 ↗
6. Stereotactic radiotherapy for hepatocellular carcinoma: Expanding the multidisciplinary armamentarium10.1111/jgh.15175 ↗
7. Clinically relevant radioresistant cells efficiently repair DNA double-strand breaks induced by X-rays10.1111/j.1349-7006.2009.01082.x ↗
8. In vitro irradiation system for radiobiological experiments10.1186/1748-717X-8-257 ↗
9. ter. 3D tumour spheroids for the prediction of the effects of radiation and hyperthermia treatments10.1038/s41598-020-58569-4 ↗
10. Cyberknife stereotactic radiosurgery and radiation therapy treatment planning system10.1016/j.meddos.2018.02.006 ↗
11. Liver-Kidney-on-Chip To Study Toxicity of Drug Metabolites10.1021/acsbiomaterials.7b00417 ↗
12. Chilov, D., Camenisch, G., Kvietikova, I., Ziegler, U., Gassmann, M., and Wenger, R.H. (2021, November 24). Induction and Nuclear Translocation of Hypoxia-Inducible Factor-1 (HIF-1): Heterodimerization with ARNT Is Not Necessary for Nuclear Accumulation of HIF-1alpha. Available online: https://www.zora.uzh.ch/id/eprint/66/.
13. The ADAM-pelvis phantom-an anthropomorphic, deformable and multimodal phantom for MRgRT10.1088/1361-6560/aafd5f ↗
14. Biological Tissue Modeling with Agar Gel Phantom for Radiation Dosimetry of 99mTc10.4236/ojrad.2014.41006 ↗
15. A novel anthropomorphic multimodality phantom for MRI-based radiotherapy quality assurance testing10.1002/mp.14027 ↗
16. Technical Note: ADAM PETer—An anthropomorphic, deformable and multimodality pelvis phantom with positron emission tomography extension for radiotherapy10.1002/mp.14597 ↗
17. Arzumanian, V.A., Kiseleva, O.I., and Poverennaya, E.V. (2021). The Curious Case of the HepG2 Cell Line: 40 Years of Expertise. Int. J. Mol. Sci., 22.10.3390/ijms222313135 ↗
18. Liver cancer cell lines distinctly mimic the metabolic gene expression pattern of the corresponding human tumours10.1186/s13046-018-0872-6 ↗
19. The Roles of HIF-1α in Radiosensitivity and Radiation-Induced Bystander Effects Under Hypoxia10.3389/fcell.2021.637454 ↗
20. Hypoxia inhibits hepcidin expression in HuH7 hepatoma cells via decreased SMAD4 signaling10.1152/ajpcell.00121.2010 ↗
21. Radiation effects of nuclear physics rays on hepatoma cells10.1515/phys-2019-0017 ↗